US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 71.170
  • -1.910-2.61%
Close Apr 24 16:00 ET
  • 70.500
  • -0.670-0.94%
Post 19:59 ET
3.37BMarket Cap-13504P/E (TTM)

About Axsome Therapeutics Company

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Company Profile

SymbolAXSM
Company NameAxsome Therapeutics
Listing DateNov 19, 2015
Issue Price9.00
Founded2012
CEODr. Herriot Tabuteau, M.D.
MarketNASDAQ
Employees545
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne World Trade Center,22nd floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10007
Phone1-212-332-3241
Websitehttp://www.axsome.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Herriot Tabuteau, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 8.32M
  • Nick Pizzie
  • Chief Financial Officer and Principal Accounting Officer
  • 3.33M
  • Mark Jacobson, M.A.
  • Chief Operating Officer
  • 3.79M
  • Lori Englebert
  • Executive Vice President, Commercial and Business Development
  • --
  • Dr. Susan Mahony, M.B.A.,PhD
  • Director
  • --
  • Mark E. Saad
  • Independent Director
  • 402.42K
  • Dr. Mark Coleman, M.D.
  • Independent Director
  • 424.92K
  • Dr. Roger A. Jeffs, PhD
  • Lead Independent Director
  • 397.42K
  • Hunter Murdock
  • General Counsel
  • 2.48M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg